Formulation Development and Characterization of Darunavir and Ritonavir Sustained Release Tablets Using Quality by Design Approach
نویسندگان
چکیده
Darunavir is a nonpeptidic inhibitor of protease and primarily metabolized by cytochrome P450 3A (CYP3A) isoenzymes. It usually coadministered with low-dose ritonavir (Darunavir/r). Ritonavir an CYP3A isoenzymes pharmacologically enhances which leads to increased plasma concentrations darunavir allows for daily lower dose. Here, we have developed combination SR formulation evaluated. In vitro drug release all formulations was carried out in dissolution medium 900ml pH 3.0, 0.05 M Sodium Phosphate Buffer + 2% Tween 20 75 RPM USP II apparatus (paddle). The results shown that, the matrix tablets good from trialed however were not releasing enough amount. F6, shows NLT 80%. So, F6 been considered as suitable tablet Ritonavir. Tablets also evaluated though Quality Design (QbD) method.
منابع مشابه
Formulation and Evaluation of Sustained Release Matrix Tablets of Glipizide
The purpose of this study was to develop a new monolithic matrix tablet to completely deliver glipizide in a zero order manner over a sustained period. Two approaches were examined using drug in a formulation that contain polymer like hydroxylpropyl methyl-cellulose K 100 (HPMCK) and Eudragit L 100. The granules were prepared by wet granulation method and thereby formulated as F-1, F-2. F...
متن کاملFormulation and Evaluation of Sustained Release Tablets Using Prunus armeniaca (L.) and Prunus domestica (L.) Gums
متن کامل
Development and Optimization of Venlafaxine Hydrochloride Sustained Release Triple Layer Tablets Adopting Quality by Design Approach
Purpose: Venlafaxine hydrochloride sustained release formulation increases patient compliance by reducing frequency of administration and it also reduces side effects like nausea and vomiting. Hence the objective of present investigation was to develop triple layer sustained release tablets of venlafaxine HCl using xanthan gum or polyethylene oxide. Methods: The venlafaxine HCl 150 mg sustained...
متن کاملformulation and evaluation of sustained release matrix tablets of glipizide
the purpose of this study was to develop a new monolithic matrix tablet to completely deliver glipizide in a zero order manner over a sustained period. two approaches were examined using drug in a formulation that contain polymer like hydroxylpropyl methyl-cellulose k 100 (hpmck) and eudragit l 100. the granules were prepared by wet granulation method and thereby formulated as f-1, f-2. f-3 and...
متن کاملFormulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
The aim of this study was to develop a sustained release hydrophilic matrix tablet of Diltiazem HCl and evaluates the effect of formulation variables (e.g. lubricant, binder, polymer content and viscosity grades of HPMC) on drug release. Twelve different formulations (F1-F12) were prepared by direct compression. The results of the physical parameters and assay were found to be within the accept...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of pharmaceutical research international
سال: 2021
ISSN: ['2456-9119']
DOI: https://doi.org/10.9734/jpri/2021/v33i53b33693